Approval · Notice of Compliance 9299 · 2008
TAMIFLU: Notice of Compliance 9299
Issued January 15, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9299
- Date
- January 15, 2008
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New capsules strengths
- Therapeutic class
- Antiviral agent
Products in this notice
Medicinal ingredients
- OSELTAMIVIR PHOSPHATE 30 MG per CAP
- OSELTAMIVIR PHOSPHATE 45 MG per CAP